NVIDIA said it is working with leading medical and research institutions worldwide on efforts tied to protein design, drug discovery, and precision cancer care. As part of that collaboration, the company released a new open-source model called RFD4-Proteina. The announcement links the partnerships to three stated goals: advancing protein design, speeding up drug discovery, and improving the precision of cancer care. No additional details on the participating institutions or the model’s technical specifications were disclosed in the source material. The update was reported by Techub News as a brief technology item.
NVIDIA said it has partnered with leading medical and research institutions globally to advance protein design, accelerate drug discovery, and improve precision in cancer care.
Part of the collaboration includes the release of a new open-source model, RFD4-Proteina.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
